drs. M. (Hilde) Jalving


  1. Sulfonylurea derivatives and cancer, friend or foe?

    Hendriks, A. M., Schrijnders, D., Kleefstra, N., de Vries, E. G. E., Bilo, H. J. G., Jalving, M. & Landman, G. W. D., 10-Aug-2019, In : European Journal of Pharmacology. p. 172598

    Research output: Contribution to journalReview articleAcademicpeer-review

  2. Checkpoint inhibitor-induced colitis shares mucosal histopathological features with inflammatory bowel and graft-versus-host disease

    Lopez, S. H., Kats-Ugurlu, G., Vries, L. D., Groot, M. D., Visschedijk, M., Jalving, M. & Haan, J. D., 1-Jul-2019, In : Cancer Research. 79, 13

    Research output: Contribution to journalArticleAcademic

  3. Association Between Pembrolizumab-related Adverse Events and Treatment Outcome in Advanced Melanoma: Results From the Dutch Expanded Access Program

    Bisschop, C., Wind, T. T., Blank, C. U., Koornstra, R. H. T., Kapiteijn, E., Van den Eertwegh, A. J. M., De Groot, J. W. B., Jalving, M. & Hospers, G. A. P., 2019, In : Journal of Immunotherapy. 42, 6, p. 208-214 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Everolimus-induced hyperglycemia: Dual efficacy of metformin

    Ariaans, G., De Jong, S., De Vries, E. G. E. & Jalving, M., 1-Oct-2014, In : Cancer Research. 74, 19, Suppl., 1 p., 4330.

    Research output: Contribution to journalMeeting AbstractAcademic

View all (44) »

  1. Young Investigator Grant Dutch

    Mathilde Jalving (Recipient), 2017


View all (1) »

  1. Supervising MD-PhD student (Anne Hendriks)

    Mathilde Jalving (Examiner)
    2016 → …

    Activity: ExaminationSupervision of PhD studentsAcademic

  2. Anneke Blackburn

    Mathilde Jalving (Host)

    Activity: Hosting a visitorAcademic

  3. MSc Experiemental Therapeutics, University of Oxford

    Mathilde Jalving (Other)

    Activity: OtherProfessional

View all (10) »

View graph of relations

ID: 223669